(Q43883289)

27 November 2017

title

Access to new medications to treat schizophrenia (English)

1 reference

27 November 2017

1 reference

Tami L Mark

1

1 reference

27 November 2017

Riad Dirani

series ordinal

2

1 reference

27 November 2017

Eric Slade

series ordinal

3

1 reference

27 November 2017

Patricia A Russo

series ordinal

4

1 reference

27 November 2017

publication date

1 February 2002

1 reference

Journal of Behavioral Health Services and Research

27 November 2017

published in

1 reference

27 November 2017

volume

29

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

15-29

1 reference

A study of general practitioners' reasons for changing their prescribing behaviour

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02287829

Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02287829

Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02287829

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02287829

Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02287829

Externalities in hospitals and physician adoption of a new surgical technology: an exploratory analysis.

21 January 2018

1 reference

12 December 2020

Ethnicity and antipsychotic response

1 reference

12 December 2020

Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary

1 reference

12 December 2020

Implications of generalists' slow adoption of zidovudine in clinical practice

1 reference

12 December 2020

How physicians choose drugs

1 reference

12 December 2020

The effect of race and sex on physicians' recommendations for cardiac catheterization

1 reference

12 December 2020

Identification and characterization of early and late prescribers in general practice.

1 reference

12 December 2020

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

1 reference

12 December 2020

The adoption of new drugs by doctors practising in group and solo practice

1 reference

12 December 2020

Race and tardive dyskinesia among outpatients at a CMHC.

1 reference

12 December 2020

Prescribers' beliefs and values as predictors of drug choices

1 reference

12 December 2020

Evaluation of drug-related movement disorders in the aged

1 reference

12 December 2020

Information sources and clinical decisions

1 reference

12 December 2020

A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic

1 reference

12 December 2020

Recent advances in the pharmacotherapy of schizophrenia

1 reference

12 December 2020

The interaction among the criteria physicians use when prescribing.

1 reference

12 December 2020

Clinical issues in the pharmacotherapy of African-Americans.

1 reference

12 December 2020

Information sources that influence physiatrists' adoption of new clinical practices

1 reference

12 December 2020

Physicians and the pharmaceutical industry: is a gift ever just a gift?

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

12 December 2020

The role of commercial sources in the adoption of a new drug

1 reference

12 December 2020

The Montgomery-Asberg Depression Scale: reliability and validity

1 reference

12 December 2020

The state of the art versus the state of the science. The diffusion of new medical technologies into practice

1 reference

12 December 2020

The effects of race on diagnosis and disposition from a psychiatric emergency service.

1 reference

12 December 2020

Rational Prescribing and Interpractitioner Variation:A Multilevel Approach

1 reference

12 December 2020

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina

1 reference

12 December 2020

Physician beliefs, attitudes, and prescribing behavior for anti-inflammatory drugs

1 reference

12 December 2020

Patterns of preference for information sources in the adoption of new drugs by specialists

1 reference

12 December 2020

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02287829

1 reference

27 November 2017

1 reference